Guardant Health Director Manuel Hidalgo Medina Acquires Shares via RSU Vesting

Guardant Health, Inc. ($GH) Insider Transaction Analysis

Overview

On September 21, 2026, Guardant Health, Inc. filed a Form 4 report on behalf of Director Manuel Hidalgo Medina. The filing details the acquisition of 232 shares of Common Stock on September 17, 2026, through the vesting of Restricted Stock Units (RSUs).

Key Transaction Details

• Insider: Manuel Hidalgo Medina
• Role: Director
• Security: Common Stock
• Transaction Code: M (Vesting/Conversion of Derivative Security)
• Shares Acquired: 232 shares
• Price per Share: $0.00
• Post-Transaction Beneficial Ownership: 5,020 shares directly held
• Derivative Holdings: Following the conversion of 232 RSUs, 5,105 unvested RSUs remain beneficially owned.

Vesting Terms

As indicated in the footnotes, the RSUs were originally granted on July 17, 2024, subject to a four-year vesting schedule: 25% vested on July 17, 2025, and the remaining 75% vests monthly over the following three years.

Market Impact & Trading Significance

This transaction carries Low trading significance. It represents a scheduled, non-discretionary equity vesting event rather than an open-market purchase or sale. No shares were sold to cover withholding taxes or traded on the open market.